Meegalla S K, Stevens G J, McQueen C A, Chen A Y, Yu C, Liu L F, Barrows L R, LaVoie E J
Department of Pharmaceutical Chemistry, Rutgers, State University of New Jersey, Piscataway 08855.
J Med Chem. 1994 Sep 30;37(20):3434-9. doi: 10.1021/jm00046a028.
The synthesis and pharmacological activity of isoindolo[1,2-b]quinazolin-12(10H)-ones and isoindolo[2,1-a]benzimidazoles related to batracylin are described. The acute toxicity of batracyclin has been associated with the formation of its N-acetyl metabolite which is a potent inducer of unscheduled DNA synthesis in rat hepatocytes. The desamino derivative and the 8-aza analog of batracylin retained the ability to inhibit topoisomerase II but did not induce unscheduled DNA synthesis. While less active than batracylin, these analogs were cytotoxic to CCRF CEM leukemia cells. The isoindolo[2,1-a]benzimidazole derivatives were inactive as topoisomerase II inhibitors and, in general, failed to exhibit comparable antitumor activity or to induce unscheduled DNA synthesis.
描述了与巴曲霉素相关的异吲哚并[1,2 - b]喹唑啉 - 12(10H)-酮和异吲哚并[2,1 - a]苯并咪唑的合成及药理活性。巴曲霉素的急性毒性与它的N - 乙酰代谢产物的形成有关,该代谢产物是大鼠肝细胞中DNA非定序合成的强效诱导剂。巴曲霉素的去氨基衍生物和8 - 氮杂类似物保留了抑制拓扑异构酶II的能力,但不诱导DNA非定序合成。虽然这些类似物的活性低于巴曲霉素,但它们对CCRF CEM白血病细胞具有细胞毒性。异吲哚并[2,1 - a]苯并咪唑衍生物作为拓扑异构酶II抑制剂无活性,并且一般未能表现出相当的抗肿瘤活性或诱导DNA非定序合成。